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Tam T. Huynh, MD, and Peter H. Lin, MD, Houston, Tex
Background: Acute mesenteric ischemia (AMI) is associated with high morbidity and mortality due in part to its
diagnostic difficulty and operative challenges. The purpose of this study was to review our experience of surgical
management in patients with this condition and to identify variables associated with adverse outcomes following surgical
interventions.
Methods:Hospital records and clinical data of all patients undergoing surgical interventions for AMIwere reviewed during
a recent 12-year period. Clinical outcomes as well as factors influencing mortality were analyzed.
Results: A total of 72 patients (41 females, overall mean age 65 years, range 34 to 83 years) were included in the study.
Thrombosis and embolism were the cause of AMI in 48 patients (67%) and 24 patients (33%), respectively. Abdominal
pain was the most common presenting symptom (96%), followed by nausea (56%). Preoperative angiogram was
performed in 61 patients (85%). All patients underwent operative interventions, which included thromboembolectomy
(n 22, 31%), mesenteric bypass grafting (n 33, 46%), patch angioplasty (n 9, 12%), reimplantation (n 5, 7%), and
endarterectomy (n  3, 4%). Bowel resection was necessary in 22 patients (31%) during the initial operation, and
second-look operation was performed in 38 patients (53%). Perioperative morbidity and 30-day mortality rates were 39%
and 31%, respectively. Univariate analysis showed renal insufficiency (P < .02), age >70 (P < .001), metabolic acidosis
(P < .02), and symptom duration (P < .005), and bowel resection in second-look operations (P < .01) were associated
with mortality. Logistic regression analysis showed age >70 (P  .03) and prolonged symptom duration (P  .02) were
independent predictors of mortality.
Conclusions: Elderly patients and those with a prolonged duration of symptoms had worse outcomes following surgical
intervention for AMI. A high index of suspicion with prompt diagnostic evaluation may reduce time delay prior to
surgical intervention, which may lead to improved patient survival. Aggressive surgical intervention should be performed
as promptly as possible in patients once the diagnosis of AMI is made. (J Vasc Surg 2007;46:467-74.)Acute mesenteric ischemia (AMI) is a potentially life-
threatening condition that has been recognized as a cause
of catastrophic abdominal events since 1875.1 Known eti-
ologies of this condition include mesenteric occlusion due
to underlying atherosclerosis, mesenteric embolism, non-
occlusive ischemia secondary to generalized visceral vaso-
spasm, and mesenteric vein thrombosis. While the hallmark
physiological aberration is related to ischemic bowel necro-
sis, reperfusion injury after prolonged ischemia with the
mediation of reactive oxygen species has now been recog-
nized as an important mechanism of cellular injury and
ultimately tissue damage.2,3
AMI has a dismal prognosis. Numerous large clinical
studies have reported mortality rates ranging from 30% to
65%.4-8 Researchers have sought to identify factors that
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doi:10.1016/j.jvs.2007.04.045might indicate an ominous prognosis and justify aggressive
initial intervention of this condition.9 Clinical studies,
which emphasize diagnostic and therapeutic algorithms,
have been reported in an effort to expedite diagnostic
work-up and treatment planning.10 In addition, revascular-
ization in patients with symptomatic intestinal isch-
emia,11,12 and aggressive anticoagulation of those in
chronic atrial fibrillation have been proposed as strategies
that will prevent the triggering pathophysiologic events for
AMI.5,6,8,13-15 Familiarity with this disease and knowledge
about clinical factors relating to treatment outcome of AMI
will undoubtedly play an important role for physicians
treating patients suffering from this condition. The objec-
tive of this study was twofold. To review the clinical out-
comes in patients with AMI who underwent surgical revas-
cularization at our institutions; and to examine clinical
variables associated with mortality following surgical revas-
cularization in patients with AMI.
PATIENTS AND METHODS
The hospital charts and clinic records of all patients
who underwent surgical interventions for AMI at the Bay-
lor College of Medicine-affiliated hospitals between July
1993 and August 2005 were reviewed. For the purpose of
the study, only cases of AMI requiring surgical treatment
secondary to mesenteric embolism or acute mesenteric
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from the medical record included demographic informa-
tion, presenting symptoms, comorbid medical conditions,
relevant physical examination findings, laboratory and ra-
diographic examinations, surgical treatment approach,
treatment outcome, and follow-up visits. Information re-
lating to the patency of surgical revascularization or timing
of recurrent mesenteric ischemic symptoms was also re-
corded. Follow-up information was obtained from a variety
of sources, which included outpatient clinic visit records,
subsequent hospital admission records, and telephone in-
terviews. In case of postoperative mortality, we attempted
to ascertain the exact cause of death either from autopsy
findings or death certificates. Factors related to mortality
following surgical treatment were assessed.
Clinical characteristics and comorbid conditions were
compared between the mesenteric embolic and thrombotic
groups. Statistical analysis was performed to determine the
association between relevant risk factors and treatment
mortality with Fisher exact test or Pearson 2 test in cate-
gorical variables. Wilcoxon rank-sum test was used to test
for differences in continuous variables. Kaplan-Meier
method was used to assess survival rate. A multivariate
model was analyzed with factors found to be significantly
associated with mortality based on univariate analysis re-
sults. In all analyses we only considered variables with at
least 80% of the data present or recorded. All statistical
analyses were performed using a statistical software pro-
gram (SAS Institute, Cary, NC). All values were expressed
as mean SEM. Statistical significance was accepted with a
Table I. Demographic information and comorbid medica
or thrombosis
Variable Mesen
No of patients
No of female patients 2
No of male patients 1
Mean age
Hypertension 2
Tobacco abuse 2
Digoxin use
Family history of cardiovascular disease 2
History of hypercoagulability
Oral contraceptive usage
History of stroke
Coronary artery disease 1
Prior myocardial infarction
Congestive heart failure 2
Atrial fibrillation
Peripheral vascular disease 2
Recent laparotomy (within 12 months)
Diabetes
Chronic mesenteric ischemic symptoms
Renal insufficiency (creatinine 1.5 mg/dL)
Hypercholesterolemia
Chronic obstructive pulmonary disease
NS, Nonsignificant.P value of less than .05.RESULTS
Patient information and clinical presentation. During
the study period, 72 patients (31 males and 41 females)
were identified who underwent surgical interventions for
AMI. The median age was 65 years (range 34 to 83).
Etiology for AMI included thrombosis in 48 patients (67%)
and embolism in 24 patients (33%). Relevant demographic
characteristics and comorbid medical conditions are listed
in Table I. It is noteworthy that patients with mesenteric
embolism were older (72 years vs 64 years; P .04) with a
greater incidence of atrial fibrillation (46% vs 13%; P .02)
compared with the thrombotic group. There were two
incidents of new onset atrial fibrillation, both in the group
that presented with embolism. All the patients with chronic
atrial fibrillation were on adequate anticoagulation.
Patients with acute mesenteric thrombosis had an in-
creased incidence of chronic mesenteric ischemic symp-
toms compared with the embolic cohort (54% vs 6%; P 
.01). There were no significant differences among the other
medical comorbidities analyzed.
Abdominal pain was the most common presenting
symptom that was documented in 94% of patients (Table
II). Among our patient cohorts, 26 patients (36%) who
presented with acute peritonitis were taken to the operating
room for immediate exploration. Other common symp-
toms on presentation included nausea (56%), vomiting
(38%), diarrhea (31%), and tachycardia (31%) (Table II).
Laboratory and radiographic evaluation. Pertinent
laboratory studies are listed in Table III. More than 90% of
the patients had abnormally elevated leukocyte counts,
dition in patient with either mesenteric embolism
hrombosis Mesenteric embolism P value
24
0%) 12 (50%) NS
0%) 12 (50%) NS
5 72  9 .04
8%) 13 (54%) NS
0%) 13 (54%) NS
%) 4 (17%) NS
4%) 15 (63%) NS
%) 1 (4%) NS
%) 1 (4%) NS
3%) 4 (17%) NS
0%) 11 (46%) NS
0%) 4 (17%) NS
8%) 14 (58%) NS
3%) 11 (46%) .02
2%) 11 (46%) NS
%) 2 (8%) NS
7%) 4 (17%) NS
%) 13 (54%) .01
%) 1 (4%) NS
7%) 5 (21%) NS
%) 2 (8%) NSl con
teric t
48
9 (6
9 (4
64 
8 (5
4 (5
3 (6
6 (5
4 (8
2 (4
6 (1
9 (4
5 (1
8 (5
6 (1
0 (4
4 (8
8 (1
3 (6
2 (4
8 (1
3 (6with a mean value of 21.4  109/ml. The second most
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tate level, which occurred in 88% of tested patients with a
mean value of 3.3 mml/L.
Plain radiographic x-ray studies of the abdomen were
both nonspecific and nondiagnostic. A total of 49 patients
(68%) were noted to have a pattern consistent with ileus.
AMI was diagnosed predominantly and definitively on the
basis of a biplanar aortic angiogram, which was performed
in 61 patients (85%). Fifteen patients who had previous
symptoms of intestinal angina and presented with acute
peritoneal findings underwent angiogram in the operating
room prior to abdominal exploration. We took this ap-
proach in order to rule out two or three vessel disease that
would imply multiple vessel bypass and decrease the explo-
ration time. Based on arteriographic appearance, accurate
diagnosis of mesenteric embolism and thrombosis was
made in 15 patients (71%) and 35 patients (88%), respec-
tively.
Abdominal computed tomography (CT) scans were
diagnostic for AMI in 38 (58%) of 65 patients who under-
went this evaluation, with the SMA occlusion as the iden-
tifying feature. Findings suggestive of compromised intes-
tinal viability or bowel necrosis caused by AMI, such as
thickened bowel wall, pneumatosis intestinalis, free perito-
neal fluid, and severe bowel dilatation, were noted in 41
patients (63%). Taken together, 43 patients (66%) who
underwent CT scan showed evidence of AMI or bowel
ischemia possibly caused by AMI. Other diagnostic evalu-
ations, which confirmed the diagnosis of AMI, included
magnetic resonance angiography (MRA) (n 4) and mes-
enteric duplex scan (n  3).
Surgical interventions. The mean duration between
the onset of AMI symptoms and surgical intervention was
16 hours (mean 0.5 to 21 hours). Late presentation in the
emergency room (ER), as well as work up of the abdominal
pain once they arrived at the ER accounted for the time
delay in most of the cases. All patients were fully heparin-
ized as soon as the diagnosis was suspected. A variety of
surgical interventions were performed, which included au-
tologous saphenous vein bypass grafting (n  22, 31%),
Table II. Presenting symptoms in patients with acute
mesenteric ischemia
Presenting symptom No of patients %
Abdominal pain 69 96%
Nausea 40 56%
Vomiting 27 38%
Peritonitis 26 36%
Diarrhea 22 31%
Tachycardia (HR 100 bpm) 22 31%
Arrhythmia 20 28%
Fever 15 21%
Hematemesis 13 18%
Constipation 6 8%
Evidence of shock 4 6%
HR, Heart rate.prosthetic bypass grafting (n  11, 15%), mesentericthromboembolectomy (n  22, 31%), patch angioplasty
(n  9, 12%), mesenteric reimplantation (n  5, 7%), and
endarterectomy (n  3, 4%). Mesenteric bypass grafting
was performed in 29 patients with mesenteric thrombosis
and four patients with mesenteric embolism. In contrast, all
patients who underwent mesenteric thromboembolectomy
had acute mesenteric embolism. Among the 33 patients
who had mesenteric bypass grafting procedures, antegrade
bypass was performed in 17 patients, in which the target
vessels included celiac artery alone (n  10), SMA alone
(n  15), hepatic artery (n  5), or middle colic artery
(n 5). In those patients who underwent an isolated celiac
artery bypass grafting, eight of them had an occluded SMA
while the remaining two patients had severely calcified
SMA that was not suitable for revascularization. All these
ten patients responded clinically following celiac artery
revascularization without recurrent mesenteric ischemic
symptoms. In all patients who underwent an antegrade
mesenteric bypass, the donor vessel was the supraceliac
aorta. On the other hand, retrograde bypass was performed
in 16 patients in which infrarenal aorta and iliac artery was
used as the donor vessel in 10 and 6 patients, respectively.
Bowel resection due to bowel necrosis was necessary in
22 patients (31%). A second look operation was performed
in 38 patients (53%). Among them, 11 patients underwent
additional bowel resection while four patients had bowel
resection only during the second abdominal exploration.
The decision to perform abdominal re-exploration was
based on clinical findings of marginally viable bowel during
the initial operation. Preoperative peritonitis was present in
20 patients (91%) who underwent bowel resection. Primary
intestinal anastomosis was performed in 10 patients (45%)
who had bowel resection while the remaining 12 patients
(55%) had either ileostomy or colostomy creation.
Treatment outcome. Perioperative complications oc-
curred in 49 patients (68%). Pneumonia, renal insufficiency
(creatinine 2.0 mg/dL), and sepsis were the most com-
mon complications, which occurred in 10 (14%), 8 (11%),
and 7 (10%) patients, respectively. Other operative compli-
cations included prolonged intubation (7 days, n  6,
8%), cardiac complications (n  5, 7%), prolonged post-
operative ileus (7 days, n  5, 7%), gastrointestinal
hemorrhage, (n  4, 6%), urinary tract infection (n  7,
10%), acalculus cholecystitis (n 2, 3%), and stroke (n
1, 1%). Tracheostomy was necessary in three patients due
to respiratory-related complications, while hemodialysis
was required in six patients due to renal failure. Among
these patients with renal failure, three patients required
temporary hemodialysis via permacath placement while the
remaining three patients required long-term hemodialysis
via forearm arteriovenous access. No difference in periop-
erative complication rate was found between patients who
had bowel resection vs those who did not. Similarly, no
difference in morbidity rate was noted in the types of bypass
graft conduit used or in methods of mesenteric revascular-
ization. Six patients had occlusion of the mesenteric arteries
in the postoperative period, which was documented by
computed tomography (CT) of the abdomen in four pa-
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three patients died during the postoperative period while
two patients underwent repeat mesenteric revascularization
with saphenous vein bypass grafting.
The overall 30-day perioperative mortality rate in our
series was 26%. The mortality rate of patients with mesen-
teric thrombosis and embolism was 25% and 28%, respec-
tively (P  NS). Four patients died either while still in the
hospital or in a rehabilitation facility. Mortality was 14% in
patients who underwent surgical interventions less than 12
hours following the onset of AMI symptoms. In contrast,
significantly higher mortality was noted in those who un-
derwent surgical interventions more than 12 hours follow-
ing the onset of AMI symptoms (75%, P  .02). Increased
mortality was also noted in patients with preoperative lac-
tate elevation greater than 2 mmol/L (P  .02) or leuko-
cytosis of greater than 18,000 cell counts/mL (P  .03).
Among those who required bowel resection, no difference
in mortality rate was found among those who had bowel
resection during the first abdominal exploration or second-
look operation. Similarly, no difference was noted in the
mortality rates when comparing those who underwent a
second-look exploration with those who did not undergo a
second-look operation, which was 31% and 33%, respec-
tively. Elderly patients with age greater or equal to 70 years
was associated with a greater mortality rate (43%) when
compared with those younger than 70 years of age (23%,
P  .01). No difference in the ischemic time was noted in
the elderly patient cohort, which was 17 6.3 hours, when
compared with the ischemic time of 16  8.7 hours in
those younger than 70 years of age.
Late deaths occurred in 23 patients (16 in the mesen-
teric thrombosis group and seven in the mesenteric embo-
lism cohort). The causes of late death included coronary
disease in seven cases, malignancy in four cases, recurrent
mesenteric ischemia in four cases, stroke in four patients,
and traumatic injury in one patient. Four patients died with
unknown cause. Using Kaplan-Meier analysis, the survival
rates were 58% and 28% at 5 and 10 years, respectively (Fig
1). The long-term patency rate of mesenteric revasculariza-
tion is shown in Fig 2. For the purpose of patency analysis,
the time of mesenteric vessel occlusion was estimated as the
Table III. Summary of laboratory findings at admission
Serum laboratory parameter
(normal value range)
No of patients who
serum test
Leukocyte count (11  109/ml) 72 (100%
Lactate level (2.0 mmol/L) 70 (97%)
Creatinine (0.8 to 1.4 mg/dL) 72 (100%
Urea nitrogen (BUN) (7-18 mg/dL) 72 (100%
Hemoglobin (13.5-17 g/dL) 72 (100%
Base deficit (2) 69 (96%)
Creatine kinase (22-328 U/L) 60 (83%)
Amylase (53-123 U/L) 68 (94%)
AST (7-28 U/L) 65 (90%)
AST, Aspartate aminotransferase.midpoint between the time of the most recent knownpatency and the time of documented mesenteric occlusion.
Late mesenteric vessel occlusion was recorded in 16 pa-
tients. The overall long-term mesenteric vessel patency
following surgical revascularization was 64% and 52% at 5
and 10 years, respectively.
Risk factor analysis of mortality. Risk factor analysis
of all demographic, preoperative, and intraoperative clinical
data in relation to mortality was performed. No significant
differences were found with regards to etiology, gender
distribution, laboratory variables, physical examination,
or diagnostic findings. Univariate analysis showed renal
insufficiency (P  .02), age 70 (P  .001), metabolic
acidosis (P .02), and symptom duration (P .005), and
bowel resection in second-look operations (P  .01) were
associated with mortality. Multivariable analysis of signifi-
cant univariate predictors identified that age 70 and
prolonged symptom duration (24 hours) were indepen-
dent predictors of mortality. Specifically, increased age is
associated with greater mortality with a relative risk ratio of
3.64 (95% confidence interval [CI], 1.2 to 4.2; P  .03)
and prolonged symptom duration is associated with greater
mortality with a relative risk ratio of 4.62 (95% CI, 1.3-5.1;
P  .02).
DISCUSSION
Acute mesenteric ischemia is a morbid condition that
has progressively become more prevalent in recent decades
with a current estimated incidence of 1 in 1000 hospital
admissions.5,7,9 In this study, which focused on the clinical
outcome of patients who underwent surgical revasculariza-
tion for AMI, mesenteric thrombosis remained the most
common cause of AMI. In addition, the majority of our
patients had no previous symptoms of intestinal angina.
Our study confirmed the findings of others in that the
nonspecific initial symptomatology makes diagnosis at an
early stage challenging.16,17 Abdominal pain was by far the
most common presenting symptom in our series, which was
noted in 96% of patients. It is noteworthy that a significant
portion of our patients, or 28%, had peritonitis with find-
ings of gangrenous intestine during the abdominal explo-
ration that necessitated bowel resection. This finding may
suggest that the classically taught dictum of “pain out of
the
Mean value
Proportion of patients with
abnormal lab (no and %)
21.4  109/ml 65 (90%)
3.3 mmol/L 64 (89%)
1.4 mg/dL 12 (17%)
18 mg/dL 17 (24%)
12.3 g/dL 9 (13%)
4 41 (59%)
319 U/L 18 (30%)
135 U/L 44 (65%)
38 U/L 42 (65%)had
)
)
)
)proportion to physical findings” is probably overlooked,
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before bowel necrosis develops.
The diagnosis of AMI requires a variety of clinical
factors, as there is not a single reliable serological or radio-
graphic test to confirm the diagnosis of AMI. Several com-
monly utilized serological studies as shown in Table III, such
as leukocytosis, elevated amylase level, or the development of
high anion gap metabolic acidosis, are suggestive rather than
pathognomonic of AMI. More recently, D-dimer has been
found to increase within as little as 30 minutes from the
onset of intestinal ischemia after ligation of the superior
mesenteric artery in experimental animal models.18-21 A
time-dependent increase in the D-dimer serum levels was
shown in these experiments.18,19 Further clinical studies
undoubtedly will be necessary in order to validate the
diagnostic importance of this serological test in AMI.
For patients who do not present with catastrophic
Fig 1. Long-term survival rate in patients undergoing surgical
revascularization for acute mesenteric ischemia using Kaplan-
Meier analysis.
Fig 2. Mesenteric vessel patency rate in patients undergoing sur-
gical revascularization for acute mesenteric ischemia using Kaplan-
Meier analysis.abdominal symptoms, imaging is of paramount impor-tance. CT scanning is a diagnostic modality commonly
utilized in patients who present with abdominal pain and
has been reported to be sensitive in the diagnosis of mes-
enteric occlusion.22,23 Dynamic CT angiography with
three-dimensional reconstruction is anticipated to add sig-
nificantly to its diagnostic value.24 The use of multidetector
raw CT angiography has been shown in animal models to
offer a 94% positive predictive value, and its use appears
promising in a clinical setting.25 We observed only 58%
accuracy in the ability of CT scan to diagnose mesenteric
ischemia. This is most likely due to equipment and software
limitations as evidenced by the fact that most of the inac-
curate CT readings were seen early in the 12-year span that
our review covers.
Despite advances in the techniques of CT imaging,
traditional digital subtraction arteriography remains of
value for these patients who present at an early stage and for
whom diagnosis is still uncertain. In addition, our experi-
ence indicates that performing angiography has several
advantages and should be pursued in the operating room
even in patients with clinical peritonitis. We found that
when the culprit vessels are defined angiographically and
confirmed intraoperatively, a more targeted approach to-
wards reconstruction of the compromised vessels can be
justified, therefore avoiding prolonged operative time. This
is of particular value in patients with chronic disease, in
whom multiple bypass grafts may be necessary; as well as in
the unstable patient who will benefit from a single bypass
procedure to the occluded vessel that has precipitated the
acute episode. In addition, balloon angioplasty and stent-
ing can be utilized in the occasional patient with hostile
abdomen that makes dissection hazardous; or the patient
with frank bowel necrosis and no available autogenous
conduit. Based on our clinical experience, we have summa-
rized a diagnostic and therapeutic algorithm in treatment
patients with suspected AMI (Fig 3).
Endovascular management as the sole treatment mo-
Fig 3. Diagnostic and treatment algorithm in patients with sus-
pected acute mesenteric ischemia.dality in cases of AMI remains controversial, since assess-
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achieved with abdominal exploration and direct bowel
inspection. That point aside, it is important to recognize
that endovascular treatment may play an alternative thera-
peutic role in patients with a prohibitive operative risk who
do not have frank peritoneal signs on physical exam. These
patients might benefit from mesenteric angioplasty and/or
stenting followed by close observation.26,27 Based on these
treatment principles, Boley and associates used arteriogra-
phy and subsequent catheter-based interventions or trans-
catheter vasodilator therapy as the initial or sole therapy of
AMI.23 Catheter-directed thrombolysis as well as percuta-
neous angioplasty have also been used with satisfactory
results in the treatment of acute mesenteric embolism with
short-term follow-up.8,28-30
Once the diagnosis of AMI is suspected, the surgeon is
faced with multiple therapeutic challenges, which includes
assessment of intestinal viability, revascularization to pre-
vent further small bowel loss, and resection of necrotic
bowel if necessary. Revascularization is usually accom-
plished with open revascularization techniques, although
endovascular strategies may also play a role as previously
described. Thirty-one percent of patients in our series had
intestinal necrosis at the time of initial operation and neces-
sitated bowel resection. Embolectomy for patients with
mesenteric embolism was performed through the root of
the small bowel mesentery, which occurred in 31% of our
patients. Among those who underwent mesenteric bypass
grafting procedures, they were constructed in either an
antegrade or retrograde orientation. Antegrade bypass is
technically more challenging, but employs the supraceliac
aorta as an inflow source, which is relatively devoid of
atherosclerotic disease. The retrograde bypass is technically
easier and faster to create and therefore advantageous for
the individual patient with labile vital signs or obese body
habitus. However, extensive iliac artery calcification and
kinking of the graft are potential problems. Similar to our
series, excellent results with either configuration have been
reported using either approach by many studies.4,8,9 When
possible, blood flow is restored to at least two mesenteric
vessels to ensure complete revascularization and prevent
future ischemic episodes,8,30 although some researchers
advocated that bypassing the superior mesenteric artery
alone is an acceptable alternative with equally good re-
sults.6,8
In our patients who required mesenteric bypass proce-
dures, prosthetic bypass graft conduit was used in 15% of
cases, which represented our preferred graft conduit of
choice because it avoided the theoretical risk of graft kink-
ing in contrast to a vein graft conduit. However, this
approach is contraindicated in the setting of intestinal
necrosis or questionable bowel viability due to the possibil-
ity of graft contamination. Saphenous vein or rifampin-
soaked polyester graft can be alternatively used for conduit
in a contaminated field if autogenous conduit is not avail-
able.8 Assessment of visceral perfusion can be performed
after reconstruction with a combination of clinical exami-
nation, palpation of small jejunal branches, and use ofcontinuous wave Doppler or intravenous injection of fluo-
rescein. Some of the perfusion disturbances detected at that
time are in fact reversible; therefore, a positive finding with
any of the above methods for assessment of intestinal
viability does not negate the value of the second look
operation.7,8 In an effort to preserve as much small bowel as
possible, only frankly necrotic bowel is initially resected and
a second look operation should be considered whenever
possible. This therapeutic principle was followed in our
study in which 38 out of the 45 patients who required
bowel resection upon initial exploration were taken back to
the operating room for a second look laparotomy. Aggres-
sive strategy with a scheduled second look laparotomy for
all the patients who are found to have necrotic bowel has
been described. However, we did not find this treatment
approach to be necessary in our experience.
In our study, the 30-day mortality rate following sur-
gical revascularization in patients with AMI was 31%. Pa-
rameters associated with increased mortality included renal
insufficiency, age, metabolic acidosis, symptom duration,
and bowel resection in second-look operations, whereas
further analysis of this data with logistic regression showed
that age 70 and prolonged symptom duration to be
independent predictors of mortality. Our findings were in
agreement with those identified in other recent se-
ries.8,30,31 Some of those predictors are in fact interrelated;
symptom duration is a variable that the clinician has control
over, since it is closely linked to a delay in diagnosis and the
time the patient spends in the emergency department or
having unnecessary diagnostic tests. This represents an
important timeline, during which incomplete resuscitation
leads to the development of volume depletion, metabolic
acidosis, and renal insufficiency. Even worse, time delay is
associated with more exacerbated ischemia reperfusion re-
sponse after blood supply to the viscera has been restored,
that leads to release of oxygen and nitrogen derived free
radicals.30,31 In addition, development of a local inflamma-
tory response results in intestinal epithelial cell damage,
whereas cytokine release produces systemic effects ad-
versely affecting organs including the lungs, liver, heart,
and the kidneys.32-35
Admittedly, there are several limitations in our study,
which were related to the retrospective nature of the study
and their potential patient selection and treatment bias.
Since only patients with recognized diagnoses were identi-
fied and analyzed, the mortality rate in our series undoubt-
edly underestimate the true fatality of this condition.More-
over, there was no treatment randomization; each patient
received treatment depending on surgeon’s preference and
in accordance with his/her individual anatomy and disease
etiology. Collecting data in this manner may be of limited
value, especially when it comes to outcome determinants.
These factors may have led to non-causal correlations and
limit the usefulness of these results, especially in light of a
small patient population for a rather uncommon disease.
Keeping these study limitations in mind, we believe that the
findings of our study remains valuable because it under-
scores the importance of early diagnosis and prompt inter-
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demonstrates that an aggressive approach in the manage-
ment of patients with AMI may improve the disheartening
mortality rates associated with this condition.
CONCLUSION
In conclusion, contemporary management of AMI re-
quires a high index of clinical suspicion that will prompt
rapid surgical intervention followed by aggressive postop-
erative care to prevent multiorgan failure, and rapidly rec-
ognize the development of recurrent mesenteric ischemia.
Older age, the presence of acidosis and renal failure, dura-
tion of symptomatology prior to intervention, and repeated
bowel resection are variables associated with increasedmor-
tality. Long-term survival rate remains poor mainly because
of associated comorbidities and the development of sys-
temic inflammatory response with subsequent postopera-
tive multi-organ failure. Until the development of more
sophisticated diagnostic methods allow for easier identifi-
cation of patients with AMI, rapid intervention in order to
decrease the time of ischemia prior to reperfusion remains
one of the most important determinants of favorable out-
come.
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